Prognosis of overall and disease-free survival in patients with grade 3 astrocytomas (anaplastic astrocytoma, WHO 2016).

Unlabelled: Anaplastic astrocytoma (AA) is a rare intracerebral tumor. Therefore, the number of studies devoted to risk factors of overall and disease-free survival is small. This single-center clinical study is devoted to various factors influencing prognosis of treatment in this group of patients.

Role of TERT mutation for treatment prognosis in patients with IDH-negative anaplastic astrocytoma.

Objective: To study the effect of mutation on overall and relapse-free survival in patients with -negative diffuse astrocytomas grade III (anaplastic gliomas).

Material And Methods: The study included 45 patients aged 45.5 years.